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Effects of acute and chronic uremia on active cation transport in rat
myocardium. As abnormalities of active cation transport could contrib-
ute to the genesis of uremic cardiomyopathy, we investigated myocar-
dial sodium pump function in rats with acute renal failure (ARF) and
with a model of experimental chronic renal failure (CRF) that has
metabolic similarities to advanced chronic uremia in humans. CRF rats
were hypertensive and had left ventricular hypertrophy (33% higher
heart: body weight ratio; P < 0.01) at four weeks compared to pair-fed
sham-operated rats. Importantly, both ouabain- and furosemide-sensi-
tive Rb uptake rates were unchanged in left ventricular myocardial
slices from CRF, and the intracellular sodium concentration was not
different from that of control rats even though skeletal muscle sodium
was increased, as we found previously (J Clin Invest 81:1197, 1988).
Insulin-stimulated, ouabain-sensitive Rb influx was also preserved.
There also were no abnormalities in myocardium cation transport in
rats with ARF. However, [3H]ouabain binding was decreased 45% in
CRF rats (P < 0.01); it was unchanged in acute uremia. Decreased
ouabain binding in chronic uremia was due entirely to fewer low affinity
[3H]ouabain binding sites (the binding affinity for ouabain was unaf-
fected). We conclude that in chronic, (but not acute) renal failure,
sodium pump number is reduced in myocardium but intracellular
sodium is unchanged and active cation flux rates are maintained. These
results emphasize that in rats with chronic uremia, intracellular sodium
homeostasis is preserved in myocardium, despite the presence of
marked abnormalities of active cation transport in skeletal muscle that
are characteristic of chronic uremia.
Although our understanding of the complex metabolic defects
that comprise the uremic syndrome has improved, many unan-
swered questions remain. Among the most fundamental is
whether there are changes in plasmalemmal ion transport due to
abnormalities of either active or passive transmembrane cation
flux pathways. Changes in intracellular ion homeostasis and
possibly membrane potential due to defective cation transport
could have a major impact on cell function and cellular metab-
olism. Moreover, changes in intracellular ion homeostasis
Present address is First Medical University Clinic. Lazarettg. 14,
1090 Vienna, Austria.
Received for publication November 27, 1989
and in revised form June 22, 1990
Accepted for publication June 28, 1990
© 1990 by the International Society of Nephrology
might influence uptake of substrates by transport processes
dependent on transmembrane ion gradients.
There is abundant evidence for abnormal sodium transport in
erythrocytes and leukocytes of uremic animals and patients
[1—6]. It is not clear whether these results can be generalized to
other organs. Besides erythrocytes, skeletal muscle is the only
human tissue in which transmembrane ion flux has been studied
extensively. Knockel and colleagues [5] observed a significant
decrease in sarcolemmal membrane potential only in patients
with advanced renal insufficiency (that is, creatinine clearance
below 6 mLfmin). As expected, the primary abnormalities in-
cluded defects in active Na and K transport; there was an
increase in intracellular sodium [Na11 and chloride [Cl—]1 levels
and a lower intracellular K concentration [K]1. It could not
be determined whether these abnormalities were accompanied
by an acquired defect in sarcolemmal Na,K-ATPase number or
turnover rate, or if other cation flux pathways were abnormal.
Another question is whether the abnormality in skeletal
muscle cation transport also is present in cardiac muscle. Such
an abnormality could cause cardiac dysfunction, but the exist-
ence of a specific uremic cardiomyopathy has remained very
controversial since its initial description [7, 8]. Rather than a
uremic defect, myocardial disease could be attributed to hyper-
tension, volume overload, anemia, coronary artery disease, or
other factors in chronic uremia that result in abnormal cardiac
function.
Over the past decade, reproducible models of chronic renal
failure (CRF) have been developed to examine uremia associ-
ated abnormalities. Recently, we reported that experimental
CRF in rats is associated with abnormal cation transport in
adipocytes and skeletal muscle and we characterized the nature
of the defect in sodium pump function [9]. As in humans with
CRF, tissue sodium content was increased. To extend these
results, we have studied rats with acute (ARF) and chronic
renal failure by examining ouabain-sensitive rubidium (86Rb)
transport (sodium pump activity), furosemide-sensitive 86Rb
transport (Na/K/Cl cotransport), myocardial intracellular so-
dium content and [3H]ouabain binding kinetics in ventricular
slices [10, 11]. As a subset of Na,K-ATPase enzyme units with
a high affinity for ouabain has been implicated in the activation
of potassium influx in response to insulin, we also quantified the
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increase in ouabain-sensitive 86Rb influx with insulin in both
types of experimental uremia [11].
Methods
Male Sprague-Dawley rats weighing 75 to 100 g were pur-
chased from Charles River Laboratory (Wilmington, Massachu-
setts, USA), 86rubidium-Cl (86Rb), [3H]ouabain, '4C-sorbitol
and 3H20 from New England Nuclear (Bedford, Massachu-
setts, USA), sodium orthovanadate from Aldrich (Milwaukee,
Wisconsin, USA) and other chemicals from Sigma Chemical
Co. (St. Louis, Missouri, USA).
All rats were housed in individual metabolic cages in a
temperature-controlled room with 12-hour light/dark cycle, and
were anesthetized with 50 mg/kg pentobarbitol i.p. To induce
ARF, both ureters were ligated through an abdominal incision;
a laparotomy without renal injury was performed in weight-
matched, control (SO) rats. Both groups were deprived of food
and water until sacrifice at 36 hours after operation to avoid the
influence of variable food intake, as ARF rats spontaneously eat
only small amounts [12]. This model exhibits the abnormal
metabolic characteristics associated with ARF [12—14]. CRF
was induced by ligating branches of the left renal artery to
infarct 5/6 of the left kidney. One week later, a right nephrec-
tomy was performed in CRF rats and a laparotomy without
kidney damage was performed in weight-matched, sham-oper-
ated (SO) rats. Pair-feeding of CRF and their respective SO
control rats was continued for at least 21 days, with each SO rat
receiving the same amount of food as eaten the previous day by
its paired CRF rat. The diet contained 44% protein consisting of
casein, RMH 3200 chow (Agway Country Foods, Syracuse,
New York, USA) and dextrin (40, 35, 25% wt/wt/wt). The
potassium content was 3.52 g and the sodium content was 1.60
g per kilogram chow. This model exhibits metabolic character-
istics of CRF [15, 16].
Systolic blood pressure of conscious, unanesthetized CRF
and control rats was measured by tail-cuff plethysmometry
using the method of Pfeffer, Pfeffer and Frohlich [17]. Animals
were trained to adjust to the restraining and heating device and
at least three measurements were taken at each session.
Aortic blood pH, serum sodium and potassium concentra-
tions, plasma urea nitrogen and serum creatinine were mea-
sured as described previously [12, 14, 16].
Myocardial slice preparation
Rats were anesthetized with pentobarbital and exsanguinated
by aortic puncture. The heart was immediately removed, the
aorta was cannulated and the coronary system was flushed with
a retrograde pressure of <100 mm Hg by perfusing with at least
10 ml of Krebs-Henseleit bicarbonate buffer. After the connec-
tive tissue and great vessels were removed, heart weight was
measured, and the right ventricle was removed and weighed.
Thin muscle slices weighing 10 to 20 mg from the left lateral
ventricular wall were preincubated for 30 minutes, and then
incubated for 30 minutes at 37°C with 0.5 pCi ['4C]sorbitol,
washed and blotted four times, weighed and homogenized in 1.5
ml 5% TCA to calculate the extracellular space.
86Rb transport of myocardial tissue
Myocardial 86Rb uptake was measured by incubating slices at
37°C in 3 ml of Krebs-Henseleit bicarbonate buffer (mM): 118
NaCI, 6 KCI, 1 CaCl2, I MgSO4, 1 KH2PO4, 25 NaHCO3 and 2
glucose; after gassing with 95% 02/5% C02, the pH was
measured and adjusted to 7.4 if necessary. After 10 minutes of
equilibration, 850 n insulin and/or 1 m ouabain and/or 1 mM
furosemide were added; all samples were done in triplicate [10,
11, 18]. Following 20 minutes of preincubation, the experiment
was started by adding 0.5 pCi/mi 86RbCl, and then regassing.
To measure uptake during the linear phase of 86Rb transport,
the myocardial slices were incubated for 30 minutes and then
transferred to tubes containing ice-cold buffer and washed and
blotted four times with cold buffer [10]. The slices were blotted,
weighed and dissolved in 0.5 ml I N NaOH in scintillation vials,
a scintillation cocktail (Dimilume, Packard, Downers Grove,
Illinois, USA) was added, and radioactivity was determined.
Results were corrected for extracellular 86Rb and expressed as
nmollg wet weight/mm.
The 86Rb influx assays were carried out in 6 mti KCI buffer
which is higher than serum potassium for either the CRF or
control rats, and somewhat lower than that of ARF rats. This
concentration was used to standardize the incubation condi-
tions, and control the specific radioactivity of 86Rb and the ratio
of Rb + and K + flux rates [19]. Although these experimental
conditions are not precisely the same as in vivo conditions,
changes in external K concentration between 4 and 8 mM
should not greatly affect sodium pump turnover rates.
influence of uremic sera on 86Rb transport
Aortic blood from CRF or SO animals was drawn into a
plastic syringe placed in ice and after clotting, centrifuged at
4°C, and the serum stored at —70°C until use [9]. Pooled sera
from CRF or SO rats were buffered with 0.3 mg/mI HEPES,
adjusted to pH 7,4 with 3 N HCI or NaOH, and the osmolality
to 285 mOsm/liter; the potassium concentration in pooled sera
from both CRF and SO rats was increased to 8 mEq/liter to
obviate the effects of any differences in the concentration of this
ion in pooled sera towards pump turnover rates or the ratio of
[86Rb] to [K] in each experiment. Myocardial slices from
normal rats weighing 145 to 165 g were preincubated at 37°C for
120 minutes in 2.5 ml of sera from uremic or control rats. To
determine ouabain-insensitive 86Rb transport, 1 mM ouabain
was added and after a 90 minute preincubation, 0.5 pCi 86Rb
were added and the flasks regassed. The reaction was termi-
nated after 30 minutes by washing four times in ice-cold buffer
and treated as described to measure 86Rb flux.
Myocardial [3Hjouabain binding
Ouabain binding was evaluated by the method of Norgaard,
Kjeldsen and Clausen [19] using a potassium-free buffer con-
taining (mM): 250 sucrose, 1 vanadate, 10 Tris-HCI, 3 MgSO,
adjusted to pH 7.3 with Tris. Myocardial slices were preincu-
bated at 37°C for 120 minutes in 5 ml of potassium-free buffer,
and then transferred to flasks with 3 ml of fresh buffer contain-
ing 2.21 pCi [3H]ouabain plus unlabelled ouabain (final concen-
tration, 10_6 M ouabain); parallel incubations in which 1 mM
unlabelled ouabain was also present were performed to evaluate
nonspecific binding. After 120 minutes, myocardial slices were
washed four times for 30 minutes each in ice-cold buffer,
weighed and processed as described above. Specific ouabain
binding (the difference between total and nonspecific binding)
was calculated as pmollg wet weight. To calculate binding
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kinetics and affinity constants, myocardial slices were incu-
bated in ouabain concentrations ranging from l0 to 3.16 x
10 M. Maximal binding and affinity constants of high and low
affinity binding sites were calculated as described by Munson
and Rodbard [20]. This method utilizes the conservation of
mass equation: T = F + R1K1F/(1 + KIF) + R2K2F/(1 + K2F),
where T is total ligand concentration, F is the concentration of
unbound ligand, R1 and R2 are the concentrations of the
(presumed) two ouabain binding sites, and K1 and K2 are the
association equilibrium binding constants in a two-site system.
The program derived by Munson and Rodbard utilizes a itera-
tive least-squares technique to generate the binding isotherm
that best fits the observed data. To determine whether a one- or
a two-site model is appropriate, the least-squares technique is
computed with and without the term for the second binding site.
If the improvement of the fit generated by the additional site
results in an F-value with a probability of less than 0.05, a
two-site model is accepted, as was the case with the data
presented in Figure 2.
Intracellular sodium
The intracellular sodium concentration of skeletal muscle and
myocardium before incubation was determined by a method
based on that of Tani and Neely [211. Rats with ARF, CRF and
their respective sham-operated controls were anesthetized,
blood vessels to both kidneys were ligated and 1 microcurie of
[IJ4C]inulin (ICN Biomedicals, Inc., Irvine, California, USA)
was injected intravenously. One hour later, epitrochlearis mus-
cles were removed, blotted and weighed, and treated as de-
scribed for myocardial slices. After removal of epitrochlearis
muscles, aortic blood was obtained and the inferior vena cava
was cannulated. The heart was perfused with 30 ml of a solution
of 0.35 M sucrose and 5 mr.t histidine through the inferior vena
cava [21]. The atria, vena cavae, aorta, and right ventricle were
rapidly removed and the left ventricle and septum were divided
into six segments which were blotted and weighed. The myo-
cardial segments and the epitrochlearis muscles were dried by
heating to 80°C for more than 24 hours to measure tissue dry
weight. Lipids were extracted by incubating the dried tissue in
2 ml of petroleum ether for at least eight hours. Petroleum ether
was removed by decanting and drying at 80°C for at least eight
hours so that fat-free dry solid weight could be measured.
Samples of dried and delipidated tissues were then incubated
for at least 48 hours in 5 ml of 10% acetic acid before the sodium
concentration of the supernatant was determined by atomic
absorption spectrometry. Intracellular sodium was calculated
as the difference between total and extracellular sodium. All
procedures were performed in plastic tubes that had been
soaked in deionized, distilled water to reduce sodium contam-
ination.
Calculations
Since individual pairs of rats that had been matched by
pair-feeding were studied, the Student's i-test for paired data
was used for most calculations. Group means of weight-
matched rats were compared when intracellular sodium was
measured. A limit of significance of P <0.05 was assumed.
Table 1. Characteristics of chronic renal failure and sham-operated
control rats
CFR SO P
Duration of renal 27.1 1.1
failure days
Duration of pair 22.9 1.1
feedings days
Initial body 112.9 3.5 111.3 3.8 NS
weight g
Weight gain 1.81 0.8 3.12 0.4 <0.05
gidays
Heart weight mg 769.6 91.1 578.0 28.1 <0.01
Right ventricular 128.4 13.5 112.4 7.5 NS
wt mg
Heart wt/body 5.05 0.42 3.17 0,07 <0.01
wt ratio mg/g
Myocardial dry! 0.220 0003 0.221 0.001 NS
wet wt ratio
Systolic blood 188.0 16.6 124.2 5.4 <0.02
pressure
mm Hg
PUN mg!dl 128.7 20.5 22.5 2.2 <0.001
K mEq!liter 4.3 0.4 4.1 0.2 NS
HCO3 mM 12.4 1.5 21.5 2.2 <0.005
Values from 7 pairs of rats presented as the mean SEM. Abbrevi-
ations are: CRF, chronic renal failure; SO, sham-operated, pair-fed
controls; PUN, plasma urea nitrogen.
Table 2. Characteristics of acute renal failure and controI rats
ARF Controls P
PUN mg!dl
K mEq!!iter
HCO3 mM
Initial body weight g
Mean weight loss g!36 hr
Heart weight mg
147.6 9.9
8.8 0.7
13.4 0.7
184.5 8.2
17.9 0.6
653.5 26.6
14.5 1.6
5.5 0.3
18.4 2.3
191.6 7.7
32.0 3.8
584.4 31.2
<0.001
<0.01
<0.01
NS
<0.01
<0.05
Values from 8 pairs of rats, presented as the mean 5EM. Abbrevi-
ations are: ARF, acute renal failure; PUN, plasma urea nitrogen.
Results
As reported previously, CRF rats were azotemic and exhib-
ited metabolic acidosis (Table 1); plasma potassium was un-
changed compared to SO rats [9, 15, 161. Despite pair-feeding,
weight gain was 40% less in CRF rats, and the final body weight
of CRF rats was significantly lower (P < 0.05). However, the
heart weight of CRF rats was 33% greater than that of SO rats,
resulting in a pronounced difference in the heart weight-to-body
weight ratio between CRF and control animals. The increase in
heart weight was due to hypertrophy of the left ventricle as the
weight of the right ventricle was not different from that of
control rats (Table 1). The ratios of dry weight/wet weight of the
heart were identical in both groups of rats, so the greater weight
could not be explained by excess tissue fluid in CRF rats (Table
I). As expected, systolic blood pressure measured in conscious,
resting animals the day before sacrifice was higher in the CRF
group (Table 1).
Acutely uremic rats were acidotic and hyperkalemic (Table
2). Weight loss was less in ARF compared to SO rats presum-
ably because of fluid retention [121. Heart weight after 36 hours
of ARF was slightly increased (+ 11%); blood pressure was not
measured, but it is unlikely that 36 hours was sufficient time for
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Rb uptake
nmol/g/min CRF SO P
Ouabain-sensitive 34.88 1.93 34.82 3.7 NS
Insulin-stimulated, 48.33 3.7 46.73 7.3 NS
ouabain-sensitive
Furosemide-sensitive 3.4 0.9 3.25 1.5 NS
Ouabain/furosemide- 11.9 3.0 13.6 3.1 NS
insensitive
[3Hjouabain binding 378 53 695 130 <0.05a
pmol/g wet weight
[3H]ouabain binding 180 26.0 272.5 43.4 NS
pmo!/ ventricle
Values from 7 pairs of rats are presented as the mean SEM.
Abbreviations are: CRF, chronic renal failure; SO, sham-operated,
pair-fed control rats.
aThis difference is significant by paired t-test, but P < 0.08 if
calculated using an unpaired t-test with a modified Bonferonni correc-
tion.
hypertension-induced hypertrophy to account for an increase in
myocardial weight.
Ouabain-sensitive 86Rb uptake by myocardium was not dif-
ferent in CRF and pair-fed SO rats (Table 3). Stimulation of the
sodium pump by insulin also was preserved in this tissue (+ 38%
increase in CRF rats vs. +34% in controls). There were no
defects in furosemide-sensitive 86Rb influx (Na/K/Cl cotrans-
port) or in ouabain- and furosemide-insensitive 86Rb influx
(passive permeability) (Table 3).
Total sodium pump number per gram of myocardium, esti-
mated by measuring specific PH]ouabain binding at 10—6 M
ouabain, was decreased 46% by CRF. This difference was of
borderline significance (P <0.05) using paired data, but was not
significant using an unpaired comparison in the 14 animals
studied (7 in each group). There was a significant, negative
correlation (r
—0.82) between pump site number and the
heart weight-to-body weight ratio in CRF rats (Fig. 1). This
relationship was not found in SO rats. There was no significant
correlation in either group between sodium pump number and
other variables, including blood pressure, the degree of
azotemia, acidosis, or serum potassium.
Using the iterative, least-squares computerized approach of
Munson and Rodbard [201, the binding data best fit a two-site
model. The tendency towards a lower number of total
[3H]ouabain binding sites was due to a reduced concentration of
low affinity binding sites (maximal binding 3.76 0.73 X 10— 10
M/g, CRF vs. 6.92 1.18 x 10'° M/g, control; P < 0.05 by
unpaired t-test; Fig. 2). The calculated association equilibrium
constants for binding of ouabain to the "low affinity" sites were
2.87 2.5 x 106 liter/M forCRF animals, and 3.81 1.09 x 106
liter/M in control animals; these values were not statistically
different. The high affinity sites in CRF rat myocardia com-
prised less than 1% (2.5 x 1012 M/g) of the total ouabain-
binding capacity (KA of 8 x i0 liter/M). We found no difference
in this component of ouabain binding between CRF and control
rats.
In ARF rats, ouabain-sensitive 86Rb transport was not dif-
ferent from that measured in myocardial slices from sham-
operated control rats (Table 4). As in hearts from CRF rats,
stimulation of the sodium pump by insulin was preserved
(+29.9%, ARF vs. +33.1%, SO), and Na/K/Cl cotransport was
not affected by ARF (Table 4). Ouabain- and furosemide-
insensitive flux rates (14.7 3.4, ARF vs. 12.2 2.9, SO
nmol/g/min) were not different statistically. These data can only
provide an estimate of passive permeability since water spaces
were not measured in all pairs of myocardial slices. In contrast
to results from CRF animals, total [3H]ouabain binding to the
myocardium was not altered by ARF (Table 4).
To investigate whether uremic sera could affect myocardial
cation flux rates acutely, myocardial slices from normal rats
were incubated in pooled scm from CRF rats and Rb uptake
rates were compared with those measured in myocardia incu-
bated in pooled sera from normal rats. Ouabain-sensitive 86Rb
7 8 uptake by myocardial slices incubated in uremic sera (27.8
1.9 nmol/g tissue/mm) was unchanged compared to 86Rb uptake
by myocardia incubated in normal sera (28.7 4.6 nmol/g
tissue/mm). However, ouabain-insensitive 86Rb influx was 42%
lower in myocardial tissue incubated in uremic sera compared
to that measured in myocardia incubated in normal sera (25.1
0.6 nmol/g/min, normal sera vs. 14.6 6.5 nmol/glmin, uremic
sera; P < 0.001). Incubation of normal myocardium in sera from
uremic rats did not have any significant effect on ouabain-
sensitive 86Rb uptake compared to control serum. This result is
consistent with that in a similar experiment in adipocytes [9]. It
is possible that potassium in the incubation media might have
dissociated an inhibitor from the sodium pump if the binding
kinetics of the inhibitor resemble those of the cardiac glyco-
sides. This seems unlikely, however, because we previously
found inhibition of skeletal muscle Na pump by uremic sera
using identical experimental conditions [9].
Since ouabain-sensitive, monovalent cation transport in rat
myocardium was unaffected by uremia, intracellular sodium
content in vivo should be unchanged. In preliminary studies, we
confirmed that inulin space in myocardium did not vary signif-
icantly at one or two hours after injection of ['4C]inulin;
subsequently, we dissected muscles after one hour equilibra-
tion. There was no significant difference in intracellular sodium
in the ventricles of CRF compared to control rats expressed
either as mMol/liter intracellular water or as mmol/kg fat-free
dry solids (Table 5). In contrast, the intracellular sodium
concentration in skeletal muscle of the same CRF rats was
Table 3. Myocardial sodium pump characteristics in chronic renal
failure and control rats
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Fig. 1. The left ventricular weight-to-body weight ratio is negatively
correlated with total ouabain binding (p,no!/g wet weight) in 7 rats with
chronic renal failure (r =
—0.82; y = 9.Bx + 92.4; P < 0.01).
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Fig. 2. Ouabain binding curves are illustrated for myocardial muscle s!ices from (A) CRF rats and (B) their sham-operated, pair-fed controls.
These curves are computer-derived using the method of Munson and Rodbard [201, plotting bound/total ligand versus the log of total ligand.
Although it was not possible to use ligand concentrations sufficiently low to generate an obvious upper plateau for the second, high affinity binding
site, the program was able to optimize values for K1 and R1 using a two-site model (Methods).
Table 4. Myocardial sodium pump characteristics in acute renal
failure and control rats
86Rb uptake
nmol/g/min ARF Controls P
Ouabain-sensitive 38.83 8,41 33.68 5.38 NS
Insulin-stimulated, ouabain- 49.55 10.3 42.33 5.24 NS
sensitive
Furosemide-sensitive 2.83 0,79 2.77 0.7 NS
[3H]ouabain binding pmol/g 743.0 119.3 728.4 54.8 NS
wet weight
Values for 8 pairs of rats are presented
Abbreviation is: ARF, acute renal failure.
as the mean SEM.
significantly increased as noted previously [9]. In acutely ure-
mic rats, the intracellular sodium concentration was below that
in sham-operated control rats; a similar pattern was observed in
epitrochlearis muscles of ARF animals, although this did not
reach statistical significance.
Discussion
Since the first reports of abnormal ouabain-sensitive cation
flux in erythrocytes of uremic patients [1], many studies have
confirmed these observations, both in red cells [reviewed in ref.
6] and leukocytes [4]. A defect in active, monovalent cation
transport may be present in other tissues of humans [5] and
animals with chronic renal insufficiency [9, 22, 23]. Finally,
uremic plasma appears to contain factors that acutely inhibit
sodium pump activity in erythrocytes. There is other evidence
for inhibitors of Na,K-ATPase activity in uremic plasma [1,
24—26], but the existence of a specific sodium pump inhibitor
remains controversial [27, 28].
We recently reported that active cation flux is abnormal in
skeletal muscle and adipocytes of CRF rats, although the
increase in sodium pump influx mediated by insulin was pre-
served [9]. In those tissues, the decreased basal ouabain-
sensitive cation flux was accompanied by a rise kn intracellular
sodium of about 30%. The mechanism for the defect in sodium
transport appeared to be somewhat different in the two tissues
because a significant decrease in [3H]ouabain binding was
present only in adipocytes, while there was a decrease in
sodium pump turnover rate but normal [3H]ouabain binding in
skeletal muscle.
To determine the extent of membrane transport abnormalities
in uremia, we investigated whether defects in sodium pump in
skeletal muscle were also present in the myocardium of uremic
rats. This was of interest because differences in Na,K-ATPase
activity in skeletal muscle and myocardium in response to other
physiologic stresses, such as hypokalemia, are well docu-
mented [29]. We found that sodium pump activity in myocardial
slices obtained from the left ventricle of either ARF or CRF
rats, as assessed by ouabain-sensitive 86Rb influx, was unaf-
fected and that insulin stimulation of 86Rb uptake was pre-
served. There were no abnormalities in Na/K/Cl cotransport
and passive permeability was unaffected. These results suggest
that intracellular sodium in the myocardium should be normal,
even though the animals were as uremic as those we found to
have abnormal sodium pump activity and a high intracellular
sodium in skeletal muscle and adipocytes [9]. In this report, we
found that intracellular sodium content in skeletal muscle was
increased in the same animals that had a normal sodium
concentration in myocardial muscle (Table 5). These results
emphasize that abnormal sodium pump function measured in
one cell or tissue cannot be generalized to all tissues or cell
types in experimental models of CRF or uremic patients.
The absence of a decreased sodium pump activity in vitro
does not mean that myocardial Na,K-ATPase activity or num-
ber was unaffected by CRF, because there was a pronounced
decrease in [3H]ouabain binding. The binding technique we
used was described by Clausen and colleagues and employs
vanadate to obtain more efficient and reproducible ouabain
binding in rat tissue [19, 30]. The decrease in binding was due to
Log,0 (total) Log,0 (total)
1066 Drum! et a!: Myocardia! cation transport in uremia
Table 5. Intracellular sodium concentration in myocardium and skeletal muscle
Myocardium Epitrochlearis
mmollliter ICW mmol/kg FFDS mol/liter ICW mmollkg FFDS
CRF
Sham-operated
9.4 1.7 (7)
9.9 1,3 (9)
26.9 5.0 (7)
30.1 3.6 (9)
26.6 3.8 (7)b
12.8 1.9 (7)
69.5 11.0 (7)
35.0 5.2 (7)
ARF
Sham-operated
6.2 0.7 (l0)
10.3 1.3 (8)
17.5 2.2 (l0)
29.2 3.7 (8)
8.6 3.2 (5)
13.0 3.8 (5)
25.1 9.5 (5)
34.3 10.6 (5)
Abbreviations are: CRF, chronic renal failure; ARF, acute renal failure; ICW, intracellular water; FFDS, fat-free dry solids. Number of rats
studied indicated in parentheses.
a p < 0.02
b p < 0.01 compared to values of sham-operated rats
a diminished number of low affinity binding sites. In rat myo-
cardium, there are at least two ouabain binding sites: a high
affinity receptor representing less than 2% of binding sites per
gram of normal tissue, and a low affinity receptor [31, 32]. We
found no change in the number of high affinity sites, but the
number of low affinity sites was reduced 46% by CRF. As the
insulin-responsive subset of sodium pumps in rat adipocytes
[11] is thought to be represented by the high affinity ouabain
binding sites or the "a+" isoform of Na,K-ATPase, our finding
that the increase in sodium pump activity with insulin is intact
in CRF is consistent with our conclusion that the number of
high affinity sites was unchanged.
The fact that sodium pump activity, both basal and insulin-
stimulated and intracellular sodium were preserved in myocar-
dium of CRF rats despite a decrease in the number of pump
sites, suggests that the turnover rate of the remaining sodium
pumps was increased. We cannot exclude the possibility that
small, unmeasured change in intracellular sodium may have
increased sodium pump turnover rates.
Available reports of sodium pump function in uremic myo-
cardium offer confusing results. Perparegkal, Bhan and Scheuer
reported decreased ouabain-sensitive inorganic phosphate re-
lease from sarcolemmal fractions of hearts from ARF, but not
CRF, rats [33]. However, CRF rats in that study were only
slightly uremic (BUN, about 20 mg/dl), and the pump activity
measurements were made only two weeks after subtotal ne-
phrectomy. Fiehn reported that the maximal rate of myocardial
Na,K-ATPase activity was decreased regardless of the duration
of CRF [34]. In contrast, Huot et al and Clough et al found that
when control and saline-supplemented, hypertensive rats were
equally (although only moderately) uremic, myocardial Na,K-
ATPase activity was decreased only in the hypertensive rats
[23, 35]. In these reports, results were obtained using optimal
substrate concentrations to evaluate maximal rates of ouabain-
sensitive phosphate release from myocardial slices or sarcolem-
mal vesicles. We did not measure maximal sodium pump
turnover rates, but our data are consistent with a decline in
maximal 86Rb flux rates per gram of ventricle because there was
a reduced number of sarcolemmal sodium pumps per gram wet
weight, assessed by [3H]ouabain binding. We also found a
correlation between the degree of hypertrophy and the number
of binding sites in CRF animals, and no difference in the number
of binding sites per ventricle compared to normal rats. Thus,
the changes in the distribution and affinity of ouabain binding
sites we observed are similar to those reported in the myocar-
dial hypertrophy associated with spontaneous and acquired
hypertension [31, 32].
The mechanism for myocardial dysfunction and left ventric-
ular hypertrophy in CRF remains unclear. Hyperparathyroid-
ism has been implicated as having a permissive effect in
progression of myocardial hypertrophy, but this does not ex-
clude hypertension or other factors in CRF as causes of
myocardial dysfunction [36—40].
In conclusion, myocardial sodium pump number is decreased
in CRF (but not in ARF) due to a decrease in the number of low
affinity, ouabain binding sites. Despite this, ouabain-sensitive,
active cation flux and tissue sodium content were unchanged in
myocardium from uremic rats in marked contrast to data from
skeletal muscle, adipocytes and erythrocytes, suggesting that
myocardial sodium pump turnover rates were either normal or
increased. Thus, even in animals with advanced uremia and
defects in intracellular sodium in other tissues, myocardial
sodium homeostasis is maintained.
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